Raymond James Financial’s Avalyn Pharma AVLN Stock Holding History
Bought
Maintained
Sold
Other funds holding AVLN
Raymond James Financial's AVLN Position: Q3 2026 in Review
Raymond James Financial sold out of Avalyn Pharma (AVLN) in Q3 2026, closing a stake of 11,483 shares — an estimated $378K sold.
Raymond James Financial first reported a position in AVLN in Q2 2026 and held it in 1 quarter. The position peaked at $378K in Q2 2026. 116 funds tracked by Wall St. Rank hold AVLN as of Q3 2026.
- Raymond James Financial reported no remaining Avalyn Pharma position as of Q3 2026 after selling out during the quarter.
- Raymond James Financial sold 11,483 Avalyn Pharma shares in Q3 2026, an estimated $378K.
- Raymond James Financial first reported a position in Avalyn Pharma in Q2 2026 and held it in 1 quarter.
- Raymond James Financial's Avalyn Pharma position peaked at $378K in Q2 2026.
- 116 funds tracked by Wall St. Rank held Avalyn Pharma as of Q3 2026.
Based on Raymond James Financial's 13F filing for Q3 2026, filed 12 Nov 2026.